Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Mylonakis

Showing results (11-20 of 451) with videos related to

Pageof 46
Sort By:
Virulence|September 27, 2016
Expanding the nematode model system: The molecular basis of inflammation and infection recovery in C. elegansGabriel Hendricks, Eleftherios Mylonakis
Expert Opinion on Pharmacotherapy|February 7, 2002
Antifungal use in HIV infectionFrancisco Marty, Eleftherios Mylonakis
Annals of Internal Medicine|February 1, 2021
In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortalityRaina Zhang, Eleftherios Mylonakis
Cellular Microbiology|August 6, 2015
Fungal-bacterial interactions and their relevance in healthMarios Arvanitis, Eleftherios Mylonakis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2015
Characteristics, Clinical Relevance, and the Role of Echinocandins in Fungal-Bacterial InteractionsMarios Arvanitis, Eleftherios Mylonakis
Annals of Internal Medicine|June 5, 2023
In older adults, an AS01Melina Awar, Eleftherios Mylonakis
Annals of Internal Medicine|May 6, 2024
In <i>Enterobacterales</i> bacteremia, antipseudomonal β-lactam de-escalation was noninferior to continuation for clinical cure at 3 to 5 dKonstantinos Ouranos, Eleftherios Mylonakis
Expert Opinion on Drug Discovery|July 5, 2022
Avenues for antifungal drug discovery and development: where to now?Stephanos Vassilopoulos, Eleftherios Mylonakis
Annals of Internal Medicine|June 6, 2022
In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or deathAthanasios Vassilopoulos, Eleftherios Mylonakis
Annals of Internal Medicine|January 15, 2019
In uncomplicated acute appendicitis, 61% of patients initially treated with antibiotics had not had appendectomy at 5 yearsMarkos Kalligeros, Eleftherios Mylonakis
Pageof 46

Showing results (11-20 of 451) with videos related to

Sort By:
Pageof 46
Virulence|September 27, 2016
Expanding the nematode model system: The molecular basis of inflammation and infection recovery in C. elegansGabriel Hendricks, Eleftherios Mylonakis
Expert Opinion on Pharmacotherapy|February 7, 2002
Antifungal use in HIV infectionFrancisco Marty, Eleftherios Mylonakis
Annals of Internal Medicine|February 1, 2021
In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortalityRaina Zhang, Eleftherios Mylonakis
Cellular Microbiology|August 6, 2015
Fungal-bacterial interactions and their relevance in healthMarios Arvanitis, Eleftherios Mylonakis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2015
Characteristics, Clinical Relevance, and the Role of Echinocandins in Fungal-Bacterial InteractionsMarios Arvanitis, Eleftherios Mylonakis
Annals of Internal Medicine|June 5, 2023
In older adults, an AS01Melina Awar, Eleftherios Mylonakis
Annals of Internal Medicine|May 6, 2024
In <i>Enterobacterales</i> bacteremia, antipseudomonal β-lactam de-escalation was noninferior to continuation for clinical cure at 3 to 5 dKonstantinos Ouranos, Eleftherios Mylonakis
Expert Opinion on Drug Discovery|July 5, 2022
Avenues for antifungal drug discovery and development: where to now?Stephanos Vassilopoulos, Eleftherios Mylonakis
Annals of Internal Medicine|June 6, 2022
In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or deathAthanasios Vassilopoulos, Eleftherios Mylonakis
Annals of Internal Medicine|January 15, 2019
In uncomplicated acute appendicitis, 61% of patients initially treated with antibiotics had not had appendectomy at 5 yearsMarkos Kalligeros, Eleftherios Mylonakis
Pageof 46